SOFIE Inc, a Theranostics company, has signed a global license with University Clinic Heidelberg for a class of molecular targeted diagnostics and radiotherapeutics
that are aimed at identifying and breaking down cancer associated fibroblasts in tumour stroma and irradiate nearby cancer cells, it was reported on Friday.
Louvain-la-Neuve, Belgium, November 08, 2018 --(PR.com)-- With the recent announcement by Novartis to acquire Endocyte (October 2018), interest from the conventional pharmaceutical industry towards radiopharmaceuticals and in particular radiotherapeutics
and radiotheranostics is clearly growing, as foreseen few years ago by MEDraysintell.
Tweedle, "Peptide-targeted diagnostics and radiotherapeutics
," Accounts of Chemical Research, vol.
Another important distinction is that both of these cases involved beta-minus--emitting radiotherapeutics
instead of alpha-emitting radiotherapeutics
and presumably at much higher doses than our patient received.
Previous studies have demonstrated that hematologic malignancies are highly sensitive to radiotherapeutics
. We anticipate observing the unique clinical benefits iodine131, a cytotoxic radioisotope, may provide in combination with our cancer-selective delivery vehicle.
A 250 W monopolar instrument (Radiotherapeutics
, Mountain View, CA, USA), with a 12-hook 14 G electrode (LeVeen needle electrode) generating a 4 cm array diameter, was used.
Rabbitts of the MRC Clinical ONcology & Radiotherapeutics
Unit, Cambridge, UK.
We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics
, and analytical instruments.
"This important Azedra trial in children with neuroblastoma underscores our full commitment to develop small molecule, targeted radiotherapeutics
that address significant unmet needs in cancers affecting both adults and children," said David S.
It is also likely to accelerate the development of molecular imaging pharmaceuticals, targeted radiotherapeutics
, as well as provide an improved understanding of cellular activity.
Corporation (Sunnyvale, CA; 408-745-3200) announced that it has joined with Scimed Life Systems, Inc.
The strong growth of radiotherapeutics
which represented 13% of the total nuclear medicine market in 2017, compared to 4% in 2013, will represent more than 60% of the US$ 26 billion nuclear medicine market by 2030.